Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu Eapen, James Buteau, Price Jackson, Catherine Mitchell, Sheng F. Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark Scalzo, J O’Brien, Shahneen Sandhu, Arun Azad, Scott Williams, Gaurav Sharma, Mohammad B. Haskali, Mathias Bressel, Kenneth Chen, Pocharapong Jenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J. Neeson, Declan G. Murphy, Michael S. Hofman (2023). Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. , 85(3), DOI: https://doi.org/10.1016/j.eururo.2023.08.026.
Article158 days agoAdministering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu Eapen, James Buteau, Price Jackson, Catherine Mitchell, Sheng F. Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark Scalzo, J O’Brien, Shahneen Sandhu, Arun Azad, Scott Williams, Gaurav Sharma, Mohammad B. Haskali, Mathias Bressel, Kenneth Chen, Pocharapong Jenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J. Neeson, Declan G. Murphy, Michael S. Hofman (2023). Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. , 85(3), DOI: https://doi.org/10.1016/j.eururo.2023.08.026.
Article158 days agoMolecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens
Kobe Yuen, Ben Tran, A. Antón, Habib Hamidi, Anthony J. Costello, Niall M. Corcoran, Nathan Lawrentschuk, Natalie Rainey, Marie C. Semira, Peter Gibbs, Sanjeev Mariathasan, Shahneen Sandhu, Edward E. Kadel (2022). Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens. , 82(9), DOI: https://doi.org/10.1002/pros.24346.
Article158 days agoStereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.
Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Sandhu, Ben Tran, Arun Azad, Jeremy Lewin, Katharine Cuff, Nitika Neha, Duncan Colyer, Paul J. Neeson, Howard Liu, Sarat Chander, Daniel Moon, Jeremy Goad, Declan G. Murphy, Nathan Lawrentschuk, David Pryor (2021). Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.. , 39(6_suppl), DOI: https://doi.org/10.1200/jco.2021.39.6_suppl.277.
Article158 days agoTumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes
Anna Trigos, Anupama Pasam, Patricia Banks, Roslyn Wallace, Christina Guo, Simon P. Keam, Heather Thorne, Catherine Mitchell, Stephen Lade, David Clouston, Alexander Hakansson, Yang Liu, Benjamin J. Blyth, Declan G. Murphy, Nathan Lawrentschuk, Damien Bolton, Daniel Moon, Phillip K. Darcy, Ygal Haupt, Scott Williams, Elena Castro, David Olmos, David L. Goode, Paul J. Neeson, Shahneen Sandhu (2022). Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes. , 10(6), DOI: https://doi.org/10.1136/jitc-2021-003744.
Article158 days ago